Cancer survivors who quit smoking sooner can live longer

September 12, 2017, University of Birmingham
Credit: University of Birmingham

Lung cancer survivors who quit smoking within a year of diagnosis will live for longer than those who continue to smoke, according to new research led by the Universities of Birmingham and Oxford.

The findings also revealed that general practitioners are comparatively less likely to intervene and offer stop- support to , than they are to people diagnosed with coronary heart disease. This juxtaposition has resulted in lower quit rates among .

The study, conducted in collaboration with the University of Nottingham and funded by the NIHR School for Primary Care Research, calls for better support for cancer patients who need help to quit smoking in the first year following diagnosis.

While just over a third of were smoking at diagnosis, those who stopped smoking and survived their treatment lived on average for 1.97 years, compared with 1.08 years for those who did not quit smoking after diagnosis, finds the study published in British Journal of Cancer.

Dr Amanda Farley, lead author and lecturer at the University of Birmingham, said "This research indicates that it is never too late to quit smoking. Although many people think that the damage is done, our research shows that even after a diagnosis of lung cancer, people can still benefit from quitting."

In linked research published in the Annals of Family Medicine, the researchers also investigate for the first time the likelihood that GPs will offer stop-smoking support, such as advice or medication, in patients with smoking-related cancer who are current smokers at the time of diagnosis, compared with current smokers diagnosed with coronary heart disease.

Using anonymised electronic records of 12,393 people with cancer to identify those who were smoking at the time of diagnosis between 1999 and 2013, the researchers find that GPs record the following on the patient record:

  • Patient record updated to reflect – 37 percent of cancer patients vs 78 percent of coronary heart disease patients;
  • Patient offered advice to quit – 24 percent of cancer patients versus 48 percent of coronary heart disease patients;
  • Smoking cessation medication prescribed to patient – 13 percent of cancer patients versus 22 percent of coronary heart disease patients.

In the year following diagnosis, around one-third (36.7 percent) of cancer patients had stopped smoking, compared with almost half (44.4 percent) of coronary heart disease patients.

While payments to GPs to manage smoking in patients with heart disease, introduced in 2004, led to a sharp increase in GPs recording their patients' smoking status and giving advice on stopping smoking, the improvement was similar for people with cancer as with heart disease.

Commenting on the research, lead author Professor Paul Aveyard, an Oxfordshire-based GP and Professor of Behavioural Medicine in Oxford University's Nuffield Department of Primary Care Health Sciences, said: "Our data from these two studies show that cancer patients receive less support to quit smoking from their GP than patients with , and while absolute quit rates have improved over time they remain lower than they should be.

"While most patients who smoke at diagnosis continue to smoke, those who quit in the first year after are likely to live for longer and more comfortably after surviving their cancer treatment than those who continue to smoke.'

"Given this finding, cancer patients who smoke would clearly benefit if GPs became more actively involved in offering support to quit smoking as they do with other smoking-related illnesses. To make this a reality for people with cancer, we need research to understand and support GPs to provide the best support possible for patients with cancer to quit smoking."

Explore further: Lung cancer patients who quit smoking live longer

Related Stories

Lung cancer patients who quit smoking live longer

July 16, 2015
(HealthDay)—Lung cancer patients live longer if they quit smoking around the time of their cancer diagnosis, a new study finds.

Many people continue to smoke after being diagnosed with cancer

January 23, 2012
A new analysis has found that a substantial number of lung and colorectal cancer patients continue to smoke after being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, ...

Cancer survivors who smoke perceive less risk from tobacco

July 2, 2015
Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Cancer diagnosis leads to higher quit rates among smokers

April 20, 2015
The largest study of its kind to date finds smokers diagnosed with cancer were more likely to quit than other smokers, supporting the hypothesis that a cancer diagnosis is a "teachable moment" that can be used to promote ...

Smokers who receive CT lung screening are more likely to quit

July 24, 2017
Smokers who undergo a CT scan of their lungs are more likely to quit than those who don't, concludes a trial led by Cardiff University.

For breast cancer patients, never too late to quit smoking

January 26, 2016
Documenting that it's never too late to quit smoking, a large study of breast cancer survivors has found that those who quit smoking after their diagnosis had a 33 percent lower risk of death as a result of breast cancer ...

Recommended for you

Non-coding DNA reveals a route by which advanced prostate cancer resists treatment

June 15, 2018
Two research teams converge on epigenetic switches that feed treatment-resistant metastatic prostate tumors. This research highlights the value of exploring gene regulation and large-scale structural changes in the cancer ...

Researchers peer inside cells to spy on cancer's on-off switch

June 15, 2018
Forty years after researchers first discovered it in fruit flies, a once-obscure cluster of proteins called PRC2 has become a key target for new cancer-fighting drugs, due to its tendency—when mutated—to bind to and silence ...

PIM-2 protein kinase regulates T-cell activity differently than PIM-1 or PIM-3 isoform

June 15, 2018
The PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity, while PIM-1 and PIM-3 are positive regulators, report Medical University of South Carolina (MUSC) investigators in an article ...

Gene testing could identify men with prostate cancer who may benefit from immunotherapy

June 14, 2018
Scientists have identified a pattern of genetic changes that could pick out men with advanced prostate cancer who are likely to benefit from immunotherapy.

Without 'yoga and chardonnay' leukemia stem cells are stressed to death

June 14, 2018
Change is stressful. The change that a healthy blood stem cell undergoes to become a leukemia stem cell (LSC) is no exception—think of healthy blood stem cells as young professionals and the transformation into an LSC as ...

Statins found to enhance efficacy of chemotherapy drug in blood cancers

June 14, 2018
A team of researchers with members affiliated with several institutions in the U.S. has found that some statins could enhance the efficacy of a chemotherapy drug used to fight blood cancers in mouse models. In their paper ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.